Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients

Low Disease Activity ◽

Observational Cohort ◽

Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study

Arthritis & Rheumatology ◽

10.1002/art.40798 ◽

2019 ◽

Vol 71 (6) ◽

pp. 892-900 ◽

Cited By ~ 32

Author(s):

Rishi J. Desai ◽

Ajinkya Pawar ◽

Michael E. Weinblatt ◽

Seoyoung C. Kim

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Venous Thromboembolism ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Comparative Risk ◽

Observational Cohort ◽

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trials

Arthritis & Rheumatism ◽

10.1002/art.22193 ◽

2006 ◽

Vol 54 (11) ◽

pp. 3399-3407 ◽

Cited By ~ 137

Author(s):

Angela Zink ◽

Anja Strangfeld ◽

Matthias Schneider ◽

Peter Herzer ◽

Franka Hierse ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trials ◽

Cohort Study ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Randomized Clinical Trials ◽

Observational Cohort ◽

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China

Frontiers in Pharmacology ◽

10.3389/fphar.2019.01476 ◽

2019 ◽

Vol 10 ◽

Author(s):

Xiaojian Ji ◽

Yiwen Wang ◽

Zhengyuan Hu ◽

Yingpei Ma ◽

Siliang Man ◽

...

Keyword(s):

Cohort Study ◽

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Prospective Observational Cohort Study ◽

Subcutaneous Tumor ◽

Observational Cohort ◽

The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor–α inhibitors versus phototherapy: An observational cohort study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.02.050 ◽

2018 ◽

Vol 79 (1) ◽

pp. 60-68 ◽

Cited By ~ 23

Author(s):

Jashin J. Wu ◽

Murali Sundaram ◽

Martin Cloutier ◽

Marjolaine Gauthier-Loiselle ◽

Annie Guérin ◽

...

Keyword(s):

Cohort Study ◽

Tumor Necrosis Factor ◽

Cardiovascular Events ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Observational Cohort ◽

Factor Α ◽

Utility-based outcomes made easy: The number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden

Arthritis Care & Research ◽

10.1002/acr.20235 ◽

2010 ◽

Vol 62 (10) ◽

pp. 1399-1406 ◽

Cited By ~ 17

Author(s):

Anders Gülfe ◽

Lars Erik Kristensen ◽

Tore Saxne ◽

Lennart T. H. Jacobsson ◽

Ingemar F. Petersson ◽

...

Keyword(s):

Cohort Study ◽

Tumor Necrosis Factor ◽

Inflammatory Arthritis ◽

Tumor Necrosis ◽

Quality Adjusted Life Year ◽

Southern Sweden ◽

Observational Cohort ◽

Necrosis Factor ◽

Quality Adjusted Life

Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

Arthritis Care & Research ◽

10.1002/acr.22596 ◽

2015 ◽

Vol 67 (10) ◽

pp. 1363-1370 ◽

Cited By ~ 12

Author(s):

Shuji Asai ◽

Toshihisa Kojima ◽

Takeshi Oguchi ◽

Atsushi Kaneko ◽

Yuji Hirano ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumor Necrosis Factor ◽

Joint Replacement ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Tumor Necrosis ◽

Large Joint ◽

AB0485 Predictive Factors for Achievement of Low Disease Activity or Remission at 52 Weeks in Switching from TNF Inhibitors to Abatacept with Background of low Dose or no Methotrexate: A Multicenter Observational Cohort Study in Japan

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1319 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1059.3-1060

Author(s):

T. Kojima ◽

N. Takahashi ◽

A. Kaneko ◽

D. Kida ◽

Y. Hirano ◽

...

Keyword(s):

Cohort Study ◽

Disease Activity ◽

Predictive Factors ◽

Low Dose ◽

Tnf Inhibitors ◽

Low Disease Activity ◽

Observational Cohort

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study

Arthritis & Rheumatology ◽

10.1002/art.40084 ◽

2017 ◽

Vol 69 (6) ◽

pp. 1154-1164 ◽

Cited By ~ 77

Author(s):

Seoyoung C. Kim ◽

Daniel H. Solomon ◽

James R. Rogers ◽

Sara Gale ◽

Micki Klearman ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Cardiovascular Safety ◽

SAT0089 Comparative cardiovascular safety of abatacept and tumor necrosis factor inhibitors in rheumatoid arthritis patients with and without type 2 diabetes: a population-based cohort study

10.1136/annrheumdis-2017-eular.2407 ◽

2017 ◽

Author(s):

EH Kang ◽

YP Jin ◽

G Brill ◽

JP Lewey ◽

EP Patorno ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Type 2 Diabetes ◽

Cohort Study ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Population Based ◽

Cardiovascular Safety ◽

Low conversion rate of QuantiFERON-TB Gold screening tests in patients treated with tumor necrosis factor inhibitors: A retrospective cohort study identifying an important practice gap

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.03.025 ◽

2018 ◽

Vol 79 (1) ◽

pp. 169-171 ◽

Cited By ~ 7

Author(s):

Jina Chung ◽

Adam B. Aronson ◽

Rithu Srikantha ◽

Scott A. Vogelgesang ◽

Karolyn A. Wanat

Keyword(s):

Cohort Study ◽

Tumor Necrosis Factor ◽

Retrospective Cohort Study ◽

Conversion Rate ◽

Retrospective Cohort ◽

Tumor Necrosis ◽

Screening Tests ◽

Practice Gap ◽